Spots Global Cancer Trial Database for Different Dose of Methotrexate for the Treatment of Meningeal Carcinomatosis
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Different Dose of Methotrexate for the Treatment of Meningeal Carcinomatosis
Official Title:
Study ID: NCT02590510
Conditions
Interventions
Study Description
Brief Summary: The main purpose of this study is to compare the effect of 10 mg and 15 mg methotrexate in the treatment of meningeal carcinomatosis.
Detailed Description:
Keywords
Eligibility
Minimum Age: 14 Years
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Contact Details
Name: Hui
Affiliation: The Second Hospital of Hebei Medical University
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
